BIOMARK SECURES FUNDING TO ACCELERATE DEVELOPMENT OF ITS LIQUID BIOPSY ASSAY IN QUEBEC

biomark-diagnostics-quebec

BIOMARK SECURES FUNDING TO ACCELERATE DEVELOPMENT OF ITS LIQUID BIOPSY ASSAY IN QUEBEC Vancouver, British Columbia – (November 16, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that its Quebec-based […]

BIOMARK OBTIENS UN FINANCEMENT POUR ACCÉLÉRER LE DÉVELOPPEMENT DE SA TECHNOLOGIE DE BIOPSIE LIQUIDE AU QUÉBEC

biomark-diagnostics-quebec

BIOMARK OBTIENS UN FINANCEMENT POUR ACCÉLÉRER LE DÉVELOPPEMENT DE SA TECHNOLOGIE DE BIOPSIE LIQUIDE AU QUÉBEC Vancouver, Colombie-Britannique – (16 novembre 2021) – BioMark Diagnostics Inc. («BioMark») (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF), une société de biotechnologie qui se consacre au développement de tests diagnostiques pour les cancers difficiles à détecter et à traiter, est […]

BioMark Recognizes and Supports The Lung Cancer Awareness Month

biomark recognizes and supports lung cancer awareness month

BioMark Recognizes and Supports the Lung Cancer Awareness Month Vancouver, British Columbia – (Nov 10, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that it recognizes and wanted to raise […]